Journal article
Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline
Abstract
CLINICAL QUESTION: In adult patients with inflammatory bowel disease, inflammatory arthritis (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis), or psoriasis taking biologic drugs, does proactive therapeutic drug monitoring (TDM) improve outcomes as compared with standard care?
CONTEXT AND CURRENT PRACTICE: Standard care for immune mediated inflammatory diseases includes prescribing biologic drugs at pre-determined doses. Dosing may …
Authors
Kawano-Dourado L; Kristianslund EK; Zeraatkar D; Jani M; Makharia G; Hazlewood G; Smith C; Jess T; Stabell C; Schatten A
Journal
The BMJ, Vol. 387, ,
Publisher
BMJ
DOI
10.1136/bmj-2024-079830
ISSN
0959-8138